Doxazosin
- Product NDC
- 55289-600
- 11-digit product format
- 552890600
- Labeler code
- 55289
- Product ID
- 55289-600_a46ee848-84b9-29cd-e053-2a95a90a5ef1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxazosin mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA075509
- Marketing category
- ANDA
- Marketing start
- 2000-10-20
- Marketing end
- 0000-00-00
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55289-600-30 | 55289060030 | 30 TABLET in 1 BOTTLE, PLASTIC (55289-600-30) | 30 tablet | 2011-04-20 | 0000-00-00 | No | No | Current |
| 55289-600-90 | 55289060090 | 90 TABLET in 1 BOTTLE, PLASTIC (55289-600-90) | 90 tablet | 2011-04-20 | 0000-00-00 | No | No | Current |